DAX+1,41 % EUR/USD-0,28 % Gold+0,57 % Öl (Brent)0,00 %

US FDA Breakthrough Therapy Designation for Mushrooms Creating Big Opportunity

Nachrichtenquelle: PR Newswire (engl.)
05.12.2019, 16:30  |  553   |   |   

Financialnewsmedia.com News Commentary

PALM BEACH, Florida, Dec. 5, 2019 /PRNewswire/ -- For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs—given out only for therapies that have shown strong preliminary evidence in treating serious medical conditions—puts new pharmaceuticals on a fast track for approval and offers "intensive guidance" from the FDA," reports Popular Science.  Even Researchers at New York University found psilocybin mushrooms caused a "rapid and sustained" reduction in anxiety and depression in patients with cancer, as reported by the Financial Post.  That's all opening a range of opportunity for companies that have already established launching cannabis products including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), HEXO Corporation (NYSE:HEXO) (TSX:HEXO), Trulieve Cannabis Corp. (CSE:TRUL)(OTCQX:TCNNF), The Green Organic Dutchman (TSX:TGOD)(OTCQX:TGODF), and OrganiGram Holdings Inc. (NASDAQ:OGI)(TSX-V:OGI).

The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWSThe Yield Growth Corp. just announced that its subsidiary Flourish Mushroom Labs Inc. has started initial consumer tasting trials for four organic mushroom coffees using a unique blend of freshly ground coffee beans and various mushroom formulations. "Great emphasis has been given to selecting quality ingredients including mushrooms that exhibit the highest  level of active components, which are assayed in the laboratory to assure efficacy and safety," says Vivek Taneja, Flourish Mushroom Labs' VP, Operations. "The consumer tasting trials will involve 100 participants and will take one month to complete and compile results. If results are satisfactory then the next stage of development will commence."  The newly developed line of coffees contain the mushroom varieties Lion's Mane, Reishi , Turkey Tale, Cordyceps and Chaga. Lion's Mane is known to be a powerful brain food that Healthline.com suggests supports memory, focus and cerebral function.  Healthline.com also states that Reishi mushrooms may help boost the immune system, reduce stress, while Turkey Tail is shown to be a powerful antioxidant that improves gut bacteria balance. Cordyceps, according to an article from the US National Library of Medicine, have shown to enhance athletic performance and support longevity. Chaga extracts, according to www.healthline.com, have been used in Russia and Northern European countries mainly to boost immunity and overall health.  These extracts have been used to treat certain cancers, diabetes and heart disease and to lower blood sugar and cholesterol. 

Seite 1 von 5
The Yield Growth Aktie jetzt für 4€ handeln - auf Smartbroker.de

Diesen Artikel teilen

Diskussion: GAZPROM - Russland Rohstoffperle

Diskussion: Timburgs Langfristdepot 2012-2022
Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
EuroCannabisNASDAQLibraBlack Friday

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren



Meistgelesene Nachrichten des Autors